Detalhe da pesquisa
1.
High mesothelin expression by immunohistochemistry predicts improved survival in pleural mesothelioma.
Histopathology
; 83(2): 202-210, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37040900
2.
The Role of E-Cadherin and microRNA on FAK Inhibitor Response in Malignant Pleural Mesothelioma (MPM).
Int J Mol Sci
; 22(19)2021 Sep 23.
Artigo
Inglês
| MEDLINE | ID: mdl-34638565
3.
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.
Lancet Oncol
; 18(10): 1386-1396, 2017 10.
Artigo
Inglês
| MEDLINE | ID: mdl-28870611
4.
Geographic and socioeconomic factors in patients with malignant pleural mesothelioma in New South Wales and their impact upon clinical outcomes.
Respirology
; 22(5): 978-985, 2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28139858
5.
Real world efficacy and toxicity of consolidation durvalumab following chemoradiotherapy in older Australian patients with unresectable stage III non-small cell lung cancer.
J Geriatr Oncol
; 15(2): 101705, 2024 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38290173
6.
Lidocaine for Neuropathic Cancer Pain (LiCPain): study protocol for a mixed-methods pilot study.
BMJ Open
; 13(2): e066125, 2023 02 21.
Artigo
Inglês
| MEDLINE | ID: mdl-36810169
7.
The minimum standard of care for managing malignant pleural mesothelioma in developing nations within the Asia-Pacific Region.
Asia Pac J Clin Oncol
; 18(3): 177-190, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-34161674
8.
GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol).
Ther Adv Med Oncol
; 14: 17588359221092486, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35465297
9.
3-Dimensional mesothelioma spheroids provide closer to natural pathophysiological tumor microenvironment for drug response studies.
Front Oncol
; 12: 973576, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36091141
10.
Evaluation of a Mainstream Model of Genetic Testing for Men With Prostate Cancer.
JCO Oncol Pract
; 17(2): e204-e216, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32970524
11.
The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer.
Lung Cancer (Auckl)
; 11: 1-11, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32021524
12.
CDKN2A and MTAP Are Useful Biomarkers Detectable by Droplet Digital PCR in Malignant Pleural Mesothelioma: A Potential Alternative Method in Diagnosis Compared to Fluorescence In Situ Hybridisation.
Front Oncol
; 10: 579327, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33304846
13.
Patterns of care and survival of older patients with malignant pleural mesothelioma.
J Geriatr Oncol
; 10(4): 573-576, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30917938
14.
High BIN1 expression has a favorable prognosis in malignant pleural mesothelioma and is associated with tumor infiltrating lymphocytes.
Lung Cancer
; 130: 35-41, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30885349
15.
Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma.
J Thorac Oncol
; 13(2): 258-272, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29113949
16.
Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma.
J Thorac Oncol
; 12(9): 1421-1433, 2017 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28629895
17.
MiR-score: a novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma.
Mol Oncol
; 9(3): 715-26, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25497279
18.
miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma.
Oncotarget
; 6(27): 23480-95, 2015 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26125439
19.
Immunohistochemistry in the diagnosis of malignant pleural mesothelioma: trends in Australia and a literature review.
Asia Pac J Clin Oncol
; 9(3): 273-9, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-23167246
20.
Glasgow prognostic score as a prognostic factor in metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy.
Clin Genitourin Cancer
; 11(4): 423-30, 2013 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-23816526